Expensify to Announce Q4 and Full Year Fiscal 2023 Results
Expensify to Announce Q4 and Full Year Fiscal 2023 Results
Join Expensify's earnings call on Thursday, February 22nd at 2pm PT / 5pm ET
Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced that the company’s Q4 and full year fiscal 2023 financial results will be released after market close on Thursday, February 22nd, 2024.
Expensify will host a call to discuss its Q4 and full year fiscal 2023 results on Thursday, February, 22nd 2024 at 2pm PT / 5pm ET. The link to the call will be available that day on the company’s Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars.
After the call, the following will be made available at investors.expensify.com:
- A full recording of the call
- An investor deck and press release summarizing financial results
To get started using Expensify or to learn more, head over to use.expensify.com.
About Expensify
Expensify is a payments superapp that helps individuals and businesses around the world simplify the way they manage money. More than 12 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, payroll, and travel booking in one app. All free. Whether you own a small business, manage a team, or close the books for your clients, Expensify makes it easy so you have more time to focus on what really matters.
Investor Relations:
Nick Tooker
investors@expensify.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240208622155/en/
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth